Annual Operating Expenses
$187.88 M
+$54.29 M+40.64%
December 1, 2024
Summary
- As of March 13, 2025, FDMT annual total operating expenses is $187.88 million, with the most recent change of +$54.29 million (+40.64%) on December 1, 2024.
- During the last 3 years, FDMT annual operating expenses has risen by +$98.51 million (+110.22%).
- FDMT annual operating expenses is now at all-time high.
Performance
FDMT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$56.12 M
+$4.98 M+9.74%
December 1, 2024
Summary
- As of March 13, 2025, FDMT quarterly total operating expenses is $56.12 million, with the most recent change of +$4.98 million (+9.74%) on December 1, 2024.
- Over the past year, FDMT quarterly operating expenses has increased by +$13.66 million (+32.16%).
- FDMT quarterly operating expenses is now at all-time high.
Performance
FDMT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FDMT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.6% | +32.2% |
| 3 y3 years | +110.2% | +64.2% |
| 5 y5 years | +257.1% | +64.2% |
FDMT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.2% | at high | +125.8% |
| 5 y | 5-year | at high | +257.1% | at high | +268.3% |
| alltime | all time | at high | +1001.1% | at high | +351.6% |
4D Molecular Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $187.88 M(+40.6%) | $56.12 M(+9.7%) |
| Sep 2024 | - | $51.13 M(+20.4%) |
| Jun 2024 | - | $42.46 M(+11.3%) |
| Mar 2024 | - | $38.16 M(+4.2%) |
| Dec 2023 | $133.59 M(+18.1%) | $36.63 M(+7.2%) |
| Sep 2023 | - | $34.18 M(+5.6%) |
| Jun 2023 | - | $32.38 M(+6.5%) |
| Mar 2023 | - | $30.40 M(+1.5%) |
| Dec 2022 | $113.16 M(+26.6%) | $29.97 M(+11.0%) |
| Sep 2022 | - | $27.00 M(-5.6%) |
| Jun 2022 | - | $28.59 M(+3.5%) |
| Mar 2022 | - | $27.61 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $89.37 M(+27.2%) | $24.86 M(+3.5%) |
| Sep 2021 | - | $24.03 M(+8.3%) |
| Jun 2021 | - | $22.18 M(+21.1%) |
| Mar 2021 | - | $18.31 M(-5.8%) |
| Dec 2020 | $70.28 M(+33.6%) | $19.45 M(+27.6%) |
| Sep 2020 | - | $15.24 M(-18.9%) |
| Jun 2020 | - | $18.78 M(+11.7%) |
| Mar 2020 | - | $16.81 M(-8.2%) |
| Dec 2019 | $52.61 M(+114.5%) | $18.32 M(+47.4%) |
| Sep 2019 | - | $12.43 M |
| Dec 2018 | $24.53 M(+43.8%) | - |
| Dec 2017 | $17.06 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual operating expenses year-on-year change?
- What is 4D Molecular Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly operating expenses year-on-year change?
What is 4D Molecular Therapeutics annual total operating expenses?
The current annual operating expenses of FDMT is $187.88 M
What is the all time high annual operating expenses for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total operating expenses is $187.88 M
What is 4D Molecular Therapeutics annual operating expenses year-on-year change?
Over the past year, FDMT annual total operating expenses has changed by +$54.29 M (+40.64%)
What is 4D Molecular Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of FDMT is $56.12 M
What is the all time high quarterly operating expenses for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total operating expenses is $56.12 M
What is 4D Molecular Therapeutics quarterly operating expenses year-on-year change?
Over the past year, FDMT quarterly total operating expenses has changed by +$13.66 M (+32.16%)